Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 4/20 | 0.44 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.44 |
| ▸ | PDE5A | O76074 | 6/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8470062 | 0.91 | CYP1A2 (0.36) | HIF1AEPAS1PDE5ACYP1A2CYP3A4 | |
| SCHEMBL8330242 | 0.90 | MAP2K4 (0.39) | HIF1AEPAS1PDE5ACYP1A2CYP3A4 | |
| SCHEMBL8470284 | 0.88 | CYP2D6 (0.41) | HIF1AEPAS1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8328669 | 0.88 | MAP2K4 (0.43) | HIF1AEPAS1PDE5ACYP1A2CYP3A4 | |
| SCHEMBL8332364 | 0.86 | PDE5A (0.41) | HIF1AEPAS1PDE5ACYP1A2CYP3A4 | |
| SCHEMBL5971777 | 0.85 | PDE5A (0.45) | HIF1AEPAS1PDE5ACYP1A2CYP3A4 | |
| SCHEMBL8329920 | 0.85 | PDE5A (0.44) | HIF1AEPAS1PDE5ASMN1; SMN2MAP2K4 | |
| SCHEMBL8471597 | 0.83 | MAP2K1 (0.41) | HIF1AEPAS1PDE5ACYP1A2CYP3A4 | |
| SCHEMBL8329288 | 0.83 | PDE5A (0.40) | PDE5ACYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8470520 | 0.81 | CYP1A2 (0.39) | HIF1ACYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012152295-A1 | PYRAZOLYL COMPOUNDS FOR USE IN REVERSING REACTIVE GLIOSIS | KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE (SA) | 2012-11-15 | — | — | WO | claimed |
| WO-2012154975-A2 | NITRIC OXIDE/CGMP PATHWAY INHIBITION OF VLA-4 RELATED CELL ADHESION | STC.UNM (US) | 2012-11-15 | — | — | WO | claimed |
| EP-2161977-A1 | USE OF ABSCISIC ACID SEED TREATMENT TO ENHANCE CORN EMERGENCE AFTER EARLY PLANTING | Valent Biosciences Corporation (US) | 2010-03-17 | — | — | EP | claimed |
| EP-2154956-A2 | SOLUTIONS FOR PERFUSING AND PRESERVING ORGANS AND TISSUES | Bayer Schering Pharma AG (DE) | 2010-02-24 | — | — | EP | claimed |
| WO-2008156859-A1 | USE OF ABSCISIC ACID SEED TREATMENT TO ENHANCE CORN EMERGENCE AFTER EARLY PLANTING | VALENT BIOSCIENCES CORPORATION (US) | 2008-12-24 | — | — | WO | claimed |
| WO-2008148474-A2 | SOLUTIONS FOR PERFUSING AND PRESERVING ORGANS AND TISSUES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-11 | — | — | WO | claimed |
| WO-2006081327-A2 | SMALL MOLECULES THAT REDUCE FUNGAL GROWTH | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2006-08-03 | — | — | WO | claimed |
| EP-1646382-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | HIF BIO INC. (US) | 2006-04-19 | — | — | EP | claimed |
| WO-2005077005-A2 | ENHANCING THE EFFECTIVENESS OF AN INHALED THERAPEUTIC GAS | THE GENERAL HOSPITAL CORPORATION (US) | 2005-08-25 | — | — | WO | claimed |
| WO-2005030121-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | HIF BIO, INC. (US) | 2005-04-07 | — | — | WO | claimed |
| WO-2004091648-A1 | METHOD FOR INHIBITING TUMOR ANGIOGENESIS AND TUMOR GROWTH | HIF BIO INC. (US) | 2004-10-28 | — | — | WO | claimed |
| EP-1220945-A2 | SCREEN FOR AXON VIABILITY | UNIVERSITY COLLEGE LONDON (GB) | 2002-07-10 | — | — | EP | claimed |
| WO-2001016359-A2 | SCREEN FOR AXON VIABILITY | UNIVERSITY COLLEGE LONDON (GB) | 2001-03-08 | — | — | WO | claimed |
| EP-3108245-B1 | METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING LOSS AND/OR DISTORTION OF TASTE OR SMELL | HENKIN ROBERT I (US) | 2020-07-22 | — | — | EP | disclosed |
| EP-3484894-A1 | TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS | Bristol-Myers Squibb Company (US) | 2019-05-22 | — | — | EP | disclosed |
| EP-3484878-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | Bristol-Myers Squibb Company (US) | 2019-05-22 | — | — | EP | disclosed |
| WO-2000027394-A1 | ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE | UNIVERSITY COLLEGE LONDON (GB) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000009711-A2 | ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) | VASOPHARM BIOTECH GMBH & CO. KG (DE) | 2000-02-24 | — | — | WO | disclosed |
| EP-0934311-A2 | NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES | BAYER AG (DE) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998016507-A2 | NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-04-23 | — | — | WO | disclosed |